ARAY Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: February 19, 2026
Report Source: 2026 2nd Quarter Report
Accuray Inc. Stock Analysis ARAY
Accuray, Inc. is a radiation therapy company, which engages in manufacturing medical equipment. The company is headquartered in Madison, Wisconsin and currently employs 990 full-time employees. The company went IPO on 2007-02-08. The firm develops, manufactures, sells and supports solutions that are designed to deliver radiation treatments for complex cases. Its solutions are designed to advance patient care: during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, it also provides services, which include post-contract customer support (warranty period services and post-warranty services), installation services, training, and other professional services.
Read More Accuray Inc (ARAY) Chart
Key Statistics of Accuray Inc (ARAY)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.29Volume
38.32MP/E Ratio (TTM)
-52 Week Range
Market Cap
54.74MAvg. Volume
3.19MDividend Yield
-Financial Metrics & Statements of Accuray Inc (ARAY)
FAQ's for Accuray Inc (ARAY)
- According to Musaffa’s Shariah screening methodology, Accuray Inc (ARAY) is currently classified as NOT HALAL as of February 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.